Top Markets
Coin of the day
Kohjin Bio Co., Ltd. Kohjin Bio Co., Ltd.

Kohjin Bio Co., Ltd.

177A
Peringkat dalam Saham #28137
Kohjin Bio Co., Ltd., established in 1981 in Sakado, Japan, and known as Kohjin... Kohjin Bio Co., Ltd., established in 1981 in Sakado, Japan, and known as Kohjin Co.,Ltd. until its rebranding in 1989, is a diversified life science enterprise. The company's core business involves the production and sale of various biological materials, including animal blood, sera, cell culture media, agar media for microbial assays, in-vitro diagnostic products, and cosmetics. Its extensive catalog for cell and tissue culture features specialized mediums crucial for virus and recombinant protein synthesis, hybridoma development, human lymphocyte cultivation, and insect cell lines. Additionally, Kohjin Bio supplies complementary items such as gas-permeable cell culture bags, cryopreservation agents, medium supplements, normal human cells along with their growth media, ES cell media, and comprehensive kits for in-vitro fertilization and early embryo culture. The firm further provides essential laboratory tools like cell separation solutions, physiological salt solutions, and a range of research reagents. Within microbiology, Kohjin Bio offers a wide array of culture media tailored for various applications. For clinical diagnostics, this includes mediums for identifying gram-positive cocci and gram-negative bacteria, susceptibility testing, general differentiation, anaerobic growth, and fungal detection, alongside tube mediums for confirmatory tests and expansion. For food safety, their products cover sterilization assessments, and the detection of E. coli, coliform bacteria, Staphylococcus spp., Bacillus cereus, and Vibrio parahaemolyticus. The company also produces mediums for total viable cell count determination and specific media for Campylobacter and fungi. The company's blood and serum division offers normal human blood, serum, and plasma, as well as pathological human serum. Its animal blood portfolio encompasses preserved, defibrinated, and hemolyzed animal blood, in addition to animal serum and plasma, with custom-designed formulations like Eagle medium also available. Beyond its manufacturing activities, Kohjin Bio engages in the breeding and distribution of laboratory animals, the sale of medical equipment, and provides contract services for animal immunization and antibody preparation. The company also manages the import and export of its diverse products and raw materials internationally.
Harga Saham
$5.62
Kapitalisasi Pasar
$28.75M
Perubahan (1 hari)
1.41%
Perubahan (1 tahun)
-54.69%
Negara
JP
Perdagangan Kohjin Bio Co., Ltd. (177A)

Kategori

Harga 177A dengan kapitalisasi pasar B
Kohjin Bio Co., Ltd. Kohjin Bio Co., Ltd.
177A
$5.62
Kapitalisasi pasar dari Kohjin Bio Co., Ltd.(177A)
Kapitalisasi Pasar: $28.75M
Per August 2026, Kohjin Bio Co., Ltd. memiliki kapitalisasi pasar sebesar $28.75M. Ini menjadikan Kohjin Bio Co., Ltd. sebagai perusahaan 28137th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Kohjin Bio Co., Ltd. dari 2024 hingga 2026
177A dibandingkan dengan 5 teratas stocks paling populer
Harga 177A Aset B Pasar B Hasil
Kohjin Bio Co., Ltd. Kohjin Bio Co., Ltd.
$1,036,960 $28.75M
$5.301T +18,437,995.29%
Kohjin Bio Co., Ltd. Kohjin Bio Co., Ltd.
$906,481 $28.75M
$4.634T +16,117,958.70%
Kohjin Bio Co., Ltd. Kohjin Bio Co., Ltd.
$810,453 $28.75M
$4.143T +14,410,497.43%
Kohjin Bio Co., Ltd. Kohjin Bio Co., Ltd.
$702,156 $28.75M
$3.589T +12,484,873.62%
Kohjin Bio Co., Ltd. Kohjin Bio Co., Ltd.
$558,878 $28.75M
$2.857T +9,937,270.88%